Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 80301-80350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05493761
Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease
PHASE4Active, not recruiting
72 participants
Started: Dec 23, 2022 · Completed: Sep 30, 2026
2 conditions2 sponsors3 locations
NCT04953910
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
PHASE1Recruiting
27 participants
Started: Dec 23, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor22 locations
NCT05531526
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)
PHASE3Active, not recruiting
1,535 participants
Started: Dec 23, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor198 locations
NCT05835609
PM534 Administered Intravenously to Patients With Advanced Solid Tumors
PHASE1Recruiting
30 participants
Started: Dec 23, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor3 locations
NCT05512351
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma
PHASE2Recruiting
80 participants
Started: Dec 23, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05689710
The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis
NARecruiting
30 participants
Started: Dec 23, 2022 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05599178
Doppler Findings in the Fetal Cerebral Blood Vessels (VA/MCA) Within 24 Hours Before Delivery and Relation With Perinatal Outcome.
N/ARecruiting
120 participants
Started: Dec 23, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05429268
Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)
PHASE3Active, not recruiting
82 participants
Started: Dec 23, 2022 · Completed: Apr 1, 2027
2 conditions1 sponsor61 locations
NCT05682703
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma.
N/ARecruiting
2,000 participants
Started: Dec 23, 2022 · Completed: Dec 20, 2025
2 conditions1 sponsor1 location
NCT05685316
COPLA® Cartilage Implant Pilot Clinical Trial
NAActive, not recruiting
20 participants
Started: Dec 23, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor6 locations
NCT05705869
Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart Failure
NARecruiting
1,000 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2032
5 conditions2 sponsors2 locations
NCT05920694
Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial
NARecruiting
20 participants
Started: Dec 22, 2022 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT05377125
Neural Mechanisms of Response Inhibition Training for OCRD
NARecruiting
118 participants
Started: Dec 22, 2022 · Completed: Aug 31, 2027
3 conditions1 sponsor1 location
NCT05615597
Evaluating the Efficacy of Para-discal Infiltration in Patients With Lateralized MODIC 1 Inflammatory Disc Disease
NARecruiting
30 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2025
3 conditions1 sponsor1 location
NCT05360888
Suicide Intervention for Alaska Native Youth
NARecruiting
300 participants
Started: Dec 22, 2022 · Completed: May 31, 2026
4 conditions2 sponsors2 locations
NCT05679401
A Study With Imlifidase in Anti-GBM Disease
PHASE3Active, not recruiting
50 participants
Started: Dec 22, 2022 · Completed: Nov 30, 2026
4 conditions1 sponsor48 locations
NCT05770570
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
PHASE2Recruiting
1,785 participants
Started: Dec 22, 2022 · Completed: Aug 11, 2026
5 conditions1 sponsor1 location
NCT05675930
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
PHASE2Recruiting
44 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2026
3 conditions1 sponsor9 locations
NCT05446298
ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer
PHASE2Active, not recruiting
58 participants
Started: Dec 22, 2022 · Completed: Jun 30, 2026
4 conditions3 sponsors21 locations
NCT05704842
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy
NARecruiting
40 participants
Started: Dec 22, 2022 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT05833269
Intercare, Mindfulness and Compassion Based Intervention for Parental Burnout
NAActive, not recruiting
250 participants
Started: Dec 22, 2022 · Completed: Jan 31, 2026
3 conditions2 sponsors1 location
NCT06840652
Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption
N/AEnrolling by invitation
120 participants
Started: Dec 22, 2022 · Completed: Jul 31, 2026
5 conditions1 sponsor1 location
NCT05305495
Empagliflozin in Acute Heart Failure
PHASE4Recruiting
25 participants
Started: Dec 22, 2022 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT05757947
Study of the No-touch Saphenous Vein Graft
NARecruiting
106 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2025
5 conditions1 sponsor1 location
NCT05647122
First in Human Study of AZD9592 in Solid Tumors
PHASE1Recruiting
403 participants
Started: Dec 22, 2022 · Completed: Oct 6, 2027
4 conditions1 sponsor50 locations
NCT05162742
Colchicine and Inflammation in Aortic Stenosis
PHASE3Active, not recruiting
150 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2025
6 conditions1 sponsor1 location
NCT05691374
Evaluation of Functional and Biomechanical Outcome by Shear-wave Elastography in the Short to Intermediate Follow-up After Arthroscopic Rotator Cuff Repair
N/ARecruiting
75 participants
Started: Dec 22, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05283330
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
PHASE1Recruiting
55 participants
Started: Dec 22, 2022 · Completed: Aug 31, 2027
6 conditions1 sponsor4 locations
NCT06239831
Postoperative Respiratory and Activity Monitoring
N/ARecruiting
30 participants
Started: Dec 22, 2022 · Completed: Jun 22, 2026
3 conditions2 sponsors1 location
NCT06099431
Mandibular Reconstruction Bone Plate
NAEnrolling by invitation
16 participants
Started: Dec 22, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05557305
Changes in Motor and Cognitive Function on Unilateral Spastic Cerebral Palsy, Associated With Videogame Therapy
NARecruiting
84 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05682755
Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT
PHASE1/PHASE2Recruiting
77 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06467929
Prospective Collection of Endoscopic and Histopathologic Data from Endoscopic Procedures Performed in UZ Gent
N/ARecruiting
510 participants
Started: Dec 22, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT05919342
"Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY SYMPHONY-HF"
NARecruiting
3,904 participants
Started: Dec 22, 2022 · Completed: Dec 21, 2032
2 conditions13 sponsors7 locations
NCT05611892
Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients
N/ARecruiting
30 participants
Started: Dec 22, 2022 · Completed: May 31, 2027
4 conditions2 sponsors1 location
NCT05313165
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NARecruiting
100 participants
Started: Dec 22, 2022 · Completed: May 1, 2027
3 conditions1 sponsor30 locations
NCT05412290
Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
PHASE1Recruiting
15 participants
Started: Dec 22, 2022 · Completed: Aug 31, 2028
6 conditions2 sponsors1 location
NCT05653388
Metastatic Leiomyosarcoma Biomarker Protocol
N/ARecruiting
200 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors10 locations
NCT06171542
Efficacy of a Single Image Guided Injection of CTM for Glenohumeral Arthritis
PHASE1Active, not recruiting
30 participants
Started: Dec 22, 2022 · Completed: Apr 30, 2025
3 conditions2 sponsors1 location
NCT06289660
Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age
N/ARecruiting
1,000 participants
Started: Dec 22, 2022 · Completed: Mar 1, 2033
1 condition1 sponsor17 locations
NCT05131919
Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic DMMR Colorectal Cancers
PHASE2Active, not recruiting
25 participants
Started: Dec 22, 2022 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT06466902
Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)
N/ARecruiting
326 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2027
10 conditions1 sponsor8 locations
NCT05757336
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
PHASE2Recruiting
50 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2026
3 conditions1 sponsor1 location
NCT05419960
Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta
N/ARecruiting
44 participants
Started: Dec 22, 2022 · Completed: Dec 22, 2027
1 condition2 sponsors1 location
NCT05527548
A Single-blind RCT to Investigate the Effect of Alendronate on Knee Function Following ACLR
PHASE4Recruiting
64 participants
Started: Dec 22, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06237803
European Myeloma Network (EMN) Sample Project
N/ARecruiting
6,000 participants
Started: Dec 21, 2022 · Completed: Dec 31, 2037
5 conditions2 sponsors30 locations
NCT05950750
Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study
N/ARecruiting
960 participants
Started: Dec 21, 2022 · Completed: Dec 21, 2026
1 condition2 sponsors1 location
NCT05862103
Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort
N/ARecruiting
15,000 participants
Started: Dec 21, 2022 · Completed: Dec 30, 2026
2 conditions1 sponsor18 locations
NCT06188598
Time-restricted Eating in Peri- and Postmenopausal Women
NARecruiting
100 participants
Started: Dec 21, 2022 · Completed: Dec 21, 2024
3 conditions1 sponsor1 location
NCT05694884
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
PHASE2Recruiting
75 participants
Started: Dec 21, 2022 · Completed: Feb 28, 2025
1 condition1 sponsor27 locations